Showing results (11-20 of 127) with videos related to
Sort By:
Pageof 13
Neurology|April 7, 2019
Natalizumab-associated progressive multifocal leukoencephalopathy in GermanyKira Blankenbach, Nicholas Schwab, Benjamin Hofner, et al.Deutsches Arzteblatt International|January 29, 2017
Interdisciplinary Risk Management in the Treatment of Multiple SclerosisJoachim Havla, Clemens Warnke, Tobias Derfuss, et al.Neuropsychiatric Disease and Treatment|September 21, 2011
Critical appraisal of the role of fingolimod in the treatment of multiple sclerosisClemens Warnke, Olaf Stüve, Hans-Peter Hartung, et al.Neuropsychiatric Disease and Treatment|June 27, 2009
Review of teriflunomide and its potential in the treatment of multiple sclerosisClemens Warnke, Gerd Meyer zu Hörste, Hans-Peter Hartung, et al.European Journal of Neurology|March 3, 2025
Successful Natalizumab Treatment of Two Female Individuals With Susac SyndromeAgni M Konitsioti, Rafael Grajewski, Mark Schlamann, et al.Journal of Neurology|September 14, 2024
Chimeric antigen receptor T-cell therapy for autoimmune diseases of the central nervous system: a systematic literature reviewAgni M Konitsioti, Harald Prüss, Sarah Laurent, et al.Current Opinion in Neurology|March 12, 2021
Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosisFinja Schweitzer, Nina N Kleineberg, Yasemin Göreci, et al.Journal of Neurology|January 27, 2022
Fitness, physical activity, and exercise in multiple sclerosis: a systematic review on current evidence for interactions with disease activity and progressionSebastian Proschinger, Puya Kuhwand, Annette Rademacher, et al.Therapeutic Advances in Neurological Disorders|September 14, 2012
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticityVerena Isabell Leussink, Leila Husseini, Clemens Warnke, et al.Journal of Neurology|March 26, 2025
MS treatment trends before, during, and after the COVID-19 pandemic: insights from the German MS RegisterAgni-Maria Konitsioti, Sarah Laurent, David Ellenberger, et al.Pageof 13